Transcriptional activation of the human epidermal growth factor receptor promoter by human p53

Molecular and Cellular Biology

Volumn 16, Issue 11, 1996, Pages 6009-6019

  Ludes Meyers, John H ^a   Subler, Mark A ^a   Shivakumar, Chittari V ^a   Munoz, Ruben M ^a   Jiang, Peng ^a   Bigger, John E ^a   Brown, Doris R ^a   Palit Deb, Swati ^a   Deb, Sumitra ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURVED DNA; DEOXYRIBONUCLEASE I; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY; GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL;

EID: 0029824890     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.11.6009     Document Type: Article

References (123)

1. Agoff, S. N., J. Hou, D. I. H. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84-87.
2. Balagurumoorthy, P., H. Sakamoto, M. S. Lewis, N. Zambrano, G. M. Clore, A. M. Gronenborn, E. Appella, and R. E. Harrington. 1995. Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. Proc. Natl. Acad. Sci. USA 92:8591-8595.
3. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. MDM2 expression is induced by wild-type p53 activity. EMBO J. 12:461-468.
4. Bargonetti, J., J. J. Manfredi, X. Chen, D. R. Marshak, and C. Prives. 1993. A proleolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dcv. 7:2565-2574.
5. Borellin, F., and R. Glazer. 1993. Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor dependent proliferation in human erythroleukemia cell line TF-1. J. Biol. Chem. 268:7923-7928.
6. Buckbinder, L., R. Talbott, K. Velasco-Miguel, I. Takenaka, B. Faha, B. R. Selzinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature (London) 377:646-649.
7. Carpenter, G. 1987. Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem. 56:881-914.
8. Carpenter, G., and S. Cohen. 1990. Epidermal growth factor. J. Biol. Chem. 265:7709-7712.
9. Chen, X., G. Farmer, H. Zhu, R. Prywes, and C. Prives. 1993. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes Dev. 7:1837-1849.
10. Chin, K.-V., K. Ueda, I. Pastan, and M. M. Gottesman. 1992. Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 255:459-462.
11. WAF1/CIP1 mediated by STAT1. Science 272:719-722.
12. Cho, Y., S. Gorina, P. D. Jeffrey, and N. P. Pavletich. 1994. Crystal structure of a tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355.
13. Church, J. G., V. J. Richardson, and A. G. Lockwood. 1992. Atypical receptor-mediated signal transduction events in the EGF-dependent growth-inhibited cell line, MDA-468. J. Cell Physiol. 153:373-380.
14. Crook, T., N. J. Marston, E. A. Sara, and K. H. Vousden. 1994. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79:817-827.
15. Crossley, M., and S. H. Orkin. 1994. Phosphorylation of the erythroid transcription factor GATA-1. J. Biol. Chem. 269:16589-16596.
16. Dameron, K. M., O. V. Volpert, M. A. Tainsky, and N. Bouck. 1994. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584.
17. Deb, S., C. T. Jackson, M. A. Subler, and D. W. Martin. 1992. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells. J. Virol. 66:6164-6170.
18. Deb, S. P., R. M. Muñoz, D. R. Brown, M. A. Subler, and S. Deb. 1994. Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9:1341-1350.
19. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554.
20. Donehower, L. A., and A. Bradley. 1993. The tumor suppressor p53. Biochim. Biophys. Acta 1155:185-205.
21. Dynaltech, B. D., T. Hoey, and R. Tjian. 1991. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 66:563-576.
22. El-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1:45-49.
23. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, D. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
24. Fantl, W. J., D. E. Johnson, and L. T. Willimas. 1993. Signalling by receptor tyrosine kinases. Annu. Rev. Biochem. 62:453-481.
25. Fields, S., and S. K. Jang. 1990. Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046-1049.
26. Fisher, D. E., L. A. Parent, and P. A. Sharp. 1992. Myc/Max and other helix-loop-helix/leucine zipper proteins bend DNA to-ward the major groove. Proc. Natl. Acad. Sci. USA 89:11779-11783.
27. Funk, W. D., D. T. Pak, R. H. Karas, W. E. Wright, and J. W. Shay. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12:2866-2871.
28. Ginsberg, D., F. Mechta, M. Yaniv, and M. Oren. 1991. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88:9979-9983.
29. Goldsmith, M. E., J. M. Gudas, E. Schneider, and K. H. Cowan. 1995. Wild-type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line. J. Biol. Chem. 270:1894-1898.
30. Greenblatt, M. S., W. P. Bennet, M. Hollstein, and C. C. Harris. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-4878.
31. Gruda, M. C., J. M. Zabolotny, J. H. Xiao, I. Davidson, and J. C. Alwine. 1993. Transcriptional activation by simian virus 40 large T antigen: interaction with multiple components of the transcription complex. Mol. Cell. Biol. 13:961-969.
32. Gualberto, A., and A. S. Baldwin. 1995. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J. Biol. Chem. 270:19680-19683.
33. Gualberto, A, M. L. Hixon, T. S. Finco, N. D. Perkins, G. J. Nabel, and A. S. Baldwin. 1995. A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat. Mol. Cell. Biol. 15:3450-3459.
34. Halazonetis, T. D., and A. N. Kandil. 1993. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12:5057-5064.
35. Haley, J., N. Whittle, P. Bennet, D. Kinchington, A. Ulrich, and M. Waterfield. 1987. The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription. Oncogene Res. 1:375-396.
36. Hinds, P. W., C. A. Finlay, R. S. Quartin, S. J. Baker, E. R. Fearon, B. Vogelstein, and A. J. Levine. 1990. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. Cell Growth Differ. 1:571-580.
37. Hollstein, M., K. Rice, M. S. Greenblatt, T. Soussi, R. Fuchs, T. Sorlie, E. Hovig, B. Smith-Sorensen, R. Montesano, and C. C. Harris. 1994. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22:3551-3555.
38. Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancer. Science 253:49-53.
39. Horikoshi, N., A. Usheva, J. Chen, A. J. Levine, R. Weinmann, and T. Shenk. 1995. Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol. Cell. Biol. 15:227-234.
40. Hoye, T., R. O. J. Weinzierl, G. Gill, J.-L. Chen, B. D. Dynlacht, and R. Tjian. 1993. Molecular cloning and functional analysis of drosophila TAF110 reveals properties expected of coactivators. Cell 72:247-260.
41. Huber, H. E., P. J. Goodhert, and P. S. Huang. 1994. Retinoblastoma protein reverses DNA bending by transcription factor E2F. J. Biol. Chem. 269:6999-7005.
42. Ishi, S., Y.-H. Xu, R. H. Stratton, B. A. Roe, G. T. Merlino, and I. Pastan. 1985. Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. USA 82: 4920-4924.
43. Jackson, P., P. Ridgway, J. Rayner, J. Noble, and A. Braithwaite. 1994. Transcriptional regulation of the PCNA promoter by p53. Biochem. Biophys. Res. Commun. 203:133-140.
44. Johnson, A. C., S. Ishi, Y. Jinno, I. Pastan, and G. T. Merlino. 1988. Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites. J. Biol. Chem. 263:5693-5699.
45. Kageyama, R., G. T. Merlino, and I. Pastan. 1988. Epidermal growth factor receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor. J. Biol. Chem. 263:6329-6336.
46. Kageyama, R., and I. Pastan. 1989. Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell 59:815-822.
47. Kastan, M. B., O. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. F. Walsh, B. S. Pluckett, B. Vogelstein, and A. J. Fornace. 1992. Participation of p53 protein in the cellular response to DNA damage. Cell 71:587-597.
48. Kern, S. E., K. W. Kinzler, A. Bruskin, D. Jaosz, P. Friedman, C. Prives, and B. Vogelstein. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708-1711.
49. Kern, S. E., J. A. Pietenpol, S. Thiagalingam, A. Seymour, K. W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830.
50. Kerppola, T. K., and T. Curran. 1991. Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity. Cell 66:317-326.
51. Kerppola, T. K., and T. Curran. 1993. Selective DNA bending by a variety of bZIF proteins. Mol. Cell. Biol. 13:5479-5489.
52. Kieser, A., H. A. Weich, G. Brandner, D. Marme, and W. Kolch. 1994. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9:963-969.
53. Kim, J., C. Zwieb, C. Wu, and S. Adhya. 1989. Bending of DNA by gene regulatory proteins: construction and use of a DNA bending vector. Gene 85:15-23.
54. Lane, D. P. 1994. p53 and human cancers. Br. Med. Bull. 50:582-599.
55. Lechner, M. S., D. H. Mack, A. B. Fincle, T. Crook, K. H. Vousden, and L. A. Laiminis. 1992. Human papilloma virus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:3045-3052.
56. Levine, A. J. 1993. The tumor suppressor genes. Annu. Rev. Biochem. 62:623-651.
57. Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumor suppressor gene. Nature (London) 351:453-456.
58. Levine, M., and J. L. Manley. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:405-408.
59. 3 cells. Carcinogenesis 13:183-187.
60. Lin, J., J. Chen, B. Elenbaas, and A. J. Levine. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes. Dev. 8:1235-1246.
61. Lin, J., A. K. Tetesky, and A. J. Levine. 1995. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 10:2387-2390.
62. Lin, Y. S., I. Ha, E. Maldonado, D. Reinberg, and M. R. Green. 1991. Binding of general transcription factor TFIEB to an acidic activating region. Nature (London) 353:569-571.
63. Liu, X., C. W. Miller, P. H. Koeffler, and A. J. Berk. 1993. The p53 activation domain binds the TATA box-binding polypeptide in holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell. Biol. 13: 3291-3300.
64. II31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. USA 92:5154-5158.
65. Ma, J., and M. Ptashne. 1987. A new class of transcriptional activators. Cell 51:113-119.
66. Marguiles, L., and P. B. Seghal. 1993. Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species. J. Biol. Chem. 268:15096-15100.
67. Martin, D. W., R. M. Muñoz, M. A. Subler, and S. Deb. 1993. p53 binds to the TATA-binding protein-TATA complex. J. Biol. Chem. 268:13062-13067.
68. Miyashita, T., S. Krajewska, M. Krajewska, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
69. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
70. Morris, G. F., J. R. Bischoff, and M. B. Mathews. 1996. Transcriptional activation of the human proliferating cell nuclear antigen promoter by p53. Proc. Natl. Acad. Sci. USA 93:895-899.
71. Motokura, T., K. Endo, K. Kumaki, E. Ogata, and I. Kyoji. 1995. Neoplastic transformation of normal rat embryo fibroblasts by a mutated p53 and an activated ras oncogene induces parathyroid hormone-related peptide gene expression and causes hypercalcemia in nude mice. J. Biol. Chem. 270: 30857-30861.
72. Natesan, S., and M. Z. Gilman. 1993. DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev. 7:2497-2509.
73. O'Connor, D. J., W.-F. Lam, S. Griffin, S. Zhong, L. C. Leighton, S. A. Burbidge, and X. Lu. 1995. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, EF1 and DP1. EMBO J. 14:6184-6192.
74. Okamoto, K., and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13:4816-4822.
75. O'Rourke, R. W., C. W. Miller, G. J. Kato, K. J. Simon, D.-L. Chen, C. V. Dang, and H. P. Koeffler. 1990. A potential transcriptional activation element in the p53 protein. Oncogene 5:1829-1832.
76. Osifchin, N. E., D. Jiang, N. Ohtani-Fujita, T. Fujita, M. Carroza, S.-J. Kim, T. Saki, and P. D. Robbins. 1994. Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter. J. Biol. Chem. 269:6383-6389.
77. Ozbun, M. A., and J. S. Butel. 1995. Tumor suppressor p53 mutations and breast cancer: a critical analysis. Ann. Cancer Res. 66:71-141.
78. Pavletich, N. P., K. A. Chambers, and C. O. Pabo. 1993. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev. 7:2556-2564.
79. Perry, M. E., J. Piette, J. A. Zawadzki, D. Harvey, and A. J. Levine. 1993. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 90:11623-11627.
80. Prives, C. 1993. Doing the right thing: feedback control and p53. Curr. Opin. Cell Biol. 5:214-218.
81. Prives, C. 1994. How loops, beta sheets, and alpha helices help us to understand p53. Cell 78:543-548.
82. Prives, C., and J. J. Manfredi. 1993. The p53 tumor suppressor protein: meeting review. Genes Dev. 7:529-534.
83. Ptashne, M. 1988. How eukaryotic transcriptional activators work. Nature (London) 335:683-689.
84. Ptashne, M., and A. A. F. Gann. 1990. Activators and targets. Nature (London) 346:329-331.
85. Ragimov, N., A. Krauskopf, N. Navot, V. Rotter, M. Oren, and Y. Aloni. 1993. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene 8:1183-1193.
86. Raycroft, L., H. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051.
87. Sabatini, P., S.-K. Chio, L. Rao, and E. White. 1995. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15:1060-1070.
88. Sachsenmaier, C., A. Radler-Pohl, R. Zinck, A. Nordheim, P. Herrlich, and H. J. Rahmsdorf. 1994. Involvement of growth factor receptors in the mammalian UVC response. Cell 78:963-972.
89. Saikumar, P., J. L. Gabriel, and E. P. Reddy. 1994. The Myb oncogene product induces DNA-bending. Oncogene 9:1279-1287.
90. Santhanam, V., A. Ray, and P. Sehgal. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 88:7605-7639.
91. Santon, J. B., M. R. Cronin, C. L. MacLeod, J. Mendelshohn, H. Masui, and G. N. Gill. 1986. Effects of epidermal growth factor receptor concentration on tumorigenecity of A431 cells in nude mice. Cancer Res. 46:4701-4705.
92. Schmidt-Ullrich, R. K., K. C. Valerie, W. Chan, and D. McWilliams. 1994. Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int. J. Radiat. Oncol. Biol. Phys. 29:813-819.
93. Seto, E., A. Usheva, G. P. Zambetti, J. Momand, N. Horikoshi, R. Weinmann, A. J. Levine, and T. Shenk. 1992. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89:12028-12032.
94. Shen, Y., and T. Shenk. 1994. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc. Natl. Acad. Sci. USA 91:8940-8944.
95. Shin, T. H., A. J. Paterson, and J. E. Kudlow. 1995. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth stimulatory role for p53. Mol. Cell. Biol. 15:4694-4701.
96. Shivakumar, C., D. R. Brown, S. Deb, and S. P. Deb. 1995. Wild-type p53 activates the human and proliferating cell nuclear antigen promoter. Mol. Cell. Biol. 15:6785-6793.
97. Soussi, T., C. C. de Fromentel, and P. May. 1990. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945-952.
98. Stoscheck, C. M., and L. E. King. 1985. Role of epidermal growth factor in carcinogenesis. Cancer Res. 46:1030-1037.
99. Strauss, B. E., C. Shivakumar, S. Palit Deb, and M. Haas. 1995. The MDR1 downstream promoter contains sequences-specific binding sites for wild-type p53. Biochem. Biophys. Res. Commun. 217:825-831.
100. Subler, M. A., D. W. Martin, and S. Deb. 1992. Inhibition of viral and cellular promoters by human wild-type p53. J. Virol. 66:4757-4762.
101. Subler, M. A., D. W. Martin, and S. Deb. 1994. Activation of the HIV-1 LTR by transforming mutants of human p53. J. Virol. 68:103-110.
102. Subler, M. A., D. W. Martin, and S. Deb. 1994. Overlapping domains on the p53 protein regulate its transcriptional activation and repression functions. Oncogene 9:1351-1359.
103. Thompson, J. F., and A. Landy. 1988. Empirical estimation of protein-induced DNA bending angles: applications to lambda site-specific recombination complexes. Nucleic Acids Res. 16:9687-9705.
104. II60. Science 267: 100-104.
105. Travers, A. A. 1990. Why bend DNA? Cell 50:177-186.
106. Truant, R., H. Xiao, C. J. Ingles, and J. Greenblatt. 1993. Direct interaction between the transcriptional activation domain of human p53 and the TATA-binding protein. J. Biol. Chem. 268:2284-2287.
107. Tsutsumi-Ishi, Y., K. Tadokoro, F. Hanaoka, and N. Tsuchida. 1995. Response of heat shock clement within the human HSP70 promoter to mutated p53 genes. Cell Growth Differ. 6:1-8.
108. Ueba, T., T. Nosaka, J. A. Takahashi, F. Shibata, R. Z. Florkiewicz, B. Vogelstein, Y. Oda, H. Kikuchi, and M. Hatanaka. 1994. Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc. Natl. Acad. Sci. USA 91: 9009-9013.
109. Unger, T., M. M. Nau, S. Segal, and J. D. Minna. 1992. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. EMBO J. 11:1383-1390.
110. Velu, T. J., L. Beguinot, W. C. Vass, M. C. Willingham, G. T. Merlino, I. Pastan, and D. R. Lowy. 1987. Epidermal growth factor dependent transformation by a human EGF receptor proto-oncogene. Science 238:1408-1410.
111. Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-526.
112. Wang, E. H., and R. Tjian. 1995. Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250. Science 263:811-814.
113. Wang, J. C., and G. N. Giaever. 1988. Action at a distance along a DNA. Science 240:300-304.
114. Wang, W., and J. D. Gralla. 1991. Differential ability of proximal and remote element pairs to cooperate in activating RNA polymerase 11 transcription. Mol. Cell. Biol. 11:4561-4571.
115. Wang, Y., M. Reed, P. Wang, J. E. Stenger, G. Mayr, J. F. Schwedes, and P. Tegtmeyer. 1993. p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7:2575-2586.
116. Wechsler, D. S., and C. V. Dang. 1992. Opposite orientations of DNA bending by c-Myc and Max. Proc. Natl. Acad. Sci. USA 89:7635-7639.
117. Wu, H.-M., and D. M. Crothers. 1984. The locus of sequence-directed and protein induced DNA bending. Nature (London) 308:509-513.
118. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J. L. Regier, S. J. Triezenberg, D. Reinberg, O. Flores, C. J. Ingles, and J. Greenblatt. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14:7013-7024.
119. Xu, J., K. L. Thompson, L. B. Shephard, L. G. Hudson, and G. N. Gill. 1993. T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. J. Biol. Chem. 268:16065-16073.
120. Zambetti, G. P., J. Bargonetti, K. Walker, C. Prives, and A. J. Levine. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev. 6:1143-1152.
121. Zastawny, R. L., R. Salvino, J. Chin, S. Benchimol, and V. Ling. 1993. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53. Oncogene 8:1529-1535.
122. Zwieb, C., and S. Adhya. 1994. Improved plasmid vectors for the analysis of protein-induced DNA bending. Methods Mol. Biol. 30:281-294.
123. Zwieb, C., and R. S. Brown. 1990. Absence of substantial bending in Xenopus laevis transcription factor IIIS-DNA complexes. Nucleic Acids Res. 18:583-587.